ReviewFrontiers in oncology2016
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
Garland Michael Upchurch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewFrontiers in oncology2016
Garland Michael Upchurch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.